AKT1 and colorectal cancer: Another inhibitor- NVP-TNKS656 used in murine xenografts models and colorectal cancer patient-derived sphere culture studies showed a high β-catenin level even in the presence of AKT and PI3K inhibitors signifying that the tankyrase inhibitor could overcome resistance to AKT and PI3K inhibitors.